论文信息 - A Phase I Trial of Immunotherapy with Lapuleucel-T (APC8024) in Patients with Refractory Metastatic Tumors that Express HER-2/neu - 字舞流文

A Phase I Trial of Immunotherapy with Lapuleucel-T (APC8024) in Patients with Refractory Metastatic Tumors that Express HER-2/neu

S. Alberts | John W. Park | M. Melisko | R. Sims | M. Frohlich | P. Peethambaram | K. Rinn | L. Jones | Nicole M. Provost | Lisa R. C. Lin